U.S. federal trademark · Serial No. 77252669 · Reg. No. 3544534
Transdermal drug delivery patches, sold with conventional drugs, proteins, peptides, genetic material, vaccines and live viral vectors, for use in the treatment and prevention of diabetes, endocrine and metabolic disorders, infectious diseases, acute and chronic pain caused by injury, surgery, cancer, and other causes, cardiovascular diseases and hematological disorders, neurological disorders, gastro-intestinal disease and neoplastic disease; transdermal drug delivery patch systems, sold with conventional drugs, proteins, peptides, genetic material, vaccines and live viral vectors, and comprised primarily of transdermal patch containing medicine, for use in the treatment and prevention of diabetes, endocrine and metabolic disorders, infectious diseases, acute and chronic pain caused by injury, surgery, cancer, and other causes, cardiovascular diseases and hematological disorders, neurological disorders, gastro-intestinal disease and neoplastic disease
Transdermal drug delivery patches sold without medication
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.